CTLA4 gene and Graves’ disease: association of Graves’ disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism-Reference-Cited by-同舟云学术

CTLA4 gene and Graves’ disease: association of Graves’ disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism

Published:2003-06 Issue:6 Volume:58 Page:732-735
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:

Author:

Vaidya B.,Oakes E. J. C.,Imrie H.,Dickinson A. J.,Perros P.,Kendall-Taylor P.,Pearce S. H. S.

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2265.2003.01778.x/fullpdf

Reference22 articles.

1. Cytotoxic T lymphocyte antigen-4 (CTLA4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis;Agarwal;Hepatology,2000

2. MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves’ disease;Allahabadia;Lancet,2001

3. CTLA4 promoter variants in patients with Graves’ disease and Hashimoto's thyroiditis;Braun;Tissue Antigens,1998

4. Graves’ ophthalmopathy: current concepts regarding pathogenesis and management;Burch;Endocrine Reviews,1993

5. CTLA4 and HLA gene susceptibility to thyroid-associated orbitopathy;Buzzetti;Lancet,1999

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between CTLA-4 +49A/G (rs231775) polymorphism and the risk of autoimmune thyroid diseases: A systematic review and meta-analysis;2023-12-15

2. Genetic variants and risk of endocrine autoimmunity in relatives of patients with Addison’s disease;Endocrine Connections;2023-04-03

3. Genotype-phenotype correlations in Graves’ disease;Best Practice & Research Clinical Endocrinology & Metabolism;2023-03

4. Immunogenetics and its utility in therapeutics;Clinical Applications of Immunogenetics;2022

5. How to use thionamide anti-thyroid drug in the young– what’s new?;Thyroid Research;2021-07-21